Cancer Biotherapy and Radiopharmaceuticals (Journal)

Ertveldt, T. (Peer reviewer)

Activity: Publication peer-review and editorial work › Publication peer-review

Description

Review of a manuscript revolving targeted radionuclide therapy in patients with a novel compound.

Period	1 Oct 2023 → 31 Oct 2023
Type of journal	Journal
ISSN	1084-9785
Degree of Recognition	International

Related content

Projects
Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.
Project: Fundamental